Nephrol Dial Transplant (1999) 14: 2922-2926
© 1999 European Renal Association-European Dialysis and Transplant Association
In vitro study of r-hirudin permeability through membranes of different haemodialysers
Max-Planck-Gesellschaft, Research Unit Pharmacological Haemostaseology, Friedrich-Schiller-University, Jena, Germany
Correspondence and offprint requests to: E. Bucha, MPG-AG `Pharmakologische Hömostaseologie', POB, D-07740 Jena, Germany.
Background. After introducing the specific thrombin inhibitor recombinant hirudin (r-hirudin) into clinical practice in cases of heparin-induced thrombocytopenia (HIT, type II) the possibility of its use as an anticoagulant during haemodialysis treatment in HIT II patients is being discussed more frequently. On the one hand, the efficient, safe and routine use of r-hirudin during haemodialyses, including the maintenance of a therapeutic blood level, presupposes that no r-hirudin will leave the circulation by passing through the dialyser membrane. On the other hand, it is important to have dialysers whose permeability to r-hirudin allows its efficient removal from the human body because, to date, no antidote is commercially available in cases of dangerously high blood concentrations of r-hirudin.
Methods. An in vitro circulation model was used to study the r-hirudin permeability of some low- and high-flux dialysers. As r-hirudin-containing vehicles, both albumin-containing saline solution and bovine blood were circulated in the blood space of the system for 2 h. Transmembrane r-hirudin passage was tested by measuring r-hirudin concentration both in the blood and dialysate space fluids using the ecarin clotting time (ECT).
Results. Low-flux dialysers with membranes made from polysulfone or regenerated cellulose proved to be almost impermeable to r-hirudin. In contrast, other low-flux membranes were partly permeable to r-hirudin (e.g. Hemophan) or even almost completely permeable (e.g. cellulose acetate). All high-flux dialysers tested were permeable to r-hirudin.
Conclusions. Only low-flux dialysers with polysulfone or regenerated cellulose membranes proved to be suitable for r-hirudin use in routine haemodialysis therapy. Other low-flux, and all high-flux, capillaries are permeable to r-hirudin and offer the possibility of lowering toxic r-hirudin concentrations after overdosing.
Keywords: haemodialysis; membrane permeability; r-hirudin
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  B. E. Gay, H.-R. Raz, H.-R. Schmid, and J. H. Beer Long-term application of lepirudin on chronic haemodialysis over 34 months after heparin-induced thrombocytopenia Nephrol. Dial. Transplant., June 1, 2007; 22(6): 1790 - 1791. [Full Text] [PDF]
|
|
|
|
 |
|
 K. Benz, M. A. Nauck, J. Bohler, and K.-G. Fischer Hemofiltration of Recombinant Hirudin by Different Hemodialyzer Membranes: Implications for Clinical Use Clin. J. Am. Soc. Nephrol., May 1, 2007; 2(3): 470 - 476. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. D. Frank, H. Farber, R. Lanzmich, J. Floege, and H. P. Kierdorf In vitro studies on hirudin elimination by haemofiltration: comparison of three high-flux membranes Nephrol. Dial. Transplant., November 1, 2002; 17(11): 1957 - 1963. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Muhl, H.-J. Siemens, P. Kujath, and H.-P. Bruch Therapy and Monitoring of Heparin-Induced Thrombocytopenia Type II in Critically Ill Patients During Continuous Venovenous Hemodiafiltration: Comparison of aPTT and Ecarin Clotting Time for Monitoring of r-Hirudin Therapy J Intensive Care Med, January 1, 2002; 17(1): 34 - 40. [Abstract] [PDF]
|
|
|
|
 |
|
 A. Koster, F. Merkle, R. Hansen, M. Loebe, H. Kuppe, R. Hetzer, G. J. Crystal, and F. Mertzlufft Elimination of Recombinant Hirudin by Modified Ultrafiltration During Simulated Cardiopulmonary Bypass: Assessment of Different Filter Systems Anesth. Analg., August 1, 2000; 91(2): 265 - 269. [Abstract] [Full Text] [PDF]
|
|